# Roche Laboratories Inc.

Canonical: https://abierto.us/vendors/roche-laboratories-inc-luklljtl2s86

- UEI: LUKLLJTL2S86
- CAGE: 66002
- Parent: Genmark Diagnostics Inc.
- Location: Nutley, NJ
- Awards in window: 3 (3 transactions), -$17,890,439 obligated, January 3, 2025 to January 9, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 3 awards, -$17,890,439

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: -$26,161
- 325414 Biological Product (except Diagnostic) Manufacturing: -$17,864,278

## Competition

- Not Competed: 3 awards

## Largest awards

- HHSO100200900116C (definitive contract): -$3,463, Barda - Aspr / Daappo / Barda DCMA. Antiviral Drugs ( for the HHS Critical Workforce (Treatment Courses) from Roche. https://www.usaspending.gov/award/CONT_AWD_HHSO100200900116C_7505_-NONE-_-NONE-/
- HHSO100200900124C (definitive contract): -$22,698, Barda - Aspr / Daappo / Barda DCMA. Close Contract and Deobligate $22,697.60 in Excess Funds. https://www.usaspending.gov/award/CONT_AWD_HHSO100200900124C_7505_-NONE-_-NONE-/
- HHSO100200600015I: -$17,864,278, Barda - Aspr / Daappo / Barda DCMA. Deobligation of Excess Funds. https://www.usaspending.gov/award/CONT_IDV_HHSO100200600015I_7505/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/roche-laboratories-inc-luklljtl2s86.